E3 PreliminaryPreliminaryPEM not requiredReview-NarrativePeer-reviewedReviewed
Standard · 3 min
Are cytokines associated with neuropsychiatric syndromes in humans?
Hickie, I, Lloyd, A · International journal of immunopharmacology · 1995 · DOI
Quick Summary
This paper suggests that immune molecules called cytokines—which your body produces during infections or inflammation—may affect your brain and behavior in ways that look like psychiatric symptoms such as depression, fatigue, loss of appetite, and difficulty thinking clearly. The authors review evidence from various illnesses where these immune-related behavioral changes happen together, including ME/CFS, and propose that cytokines may be the biological link between immune activation and these symptoms.
Why It Matters
This early conceptual paper provided important theoretical framework for understanding why ME/CFS patients experience both immune abnormalities and neuropsychiatric symptoms like cognitive impairment and fatigue—suggesting these are not separate problems but linked through cytokine signaling in the brain. For researchers, it identified specific biological mechanisms and encouraged systematic investigation of immune-behavior relationships that have since become central to ME/CFS research.
Observed Findings
Neuropsychiatric symptoms (depression, cognitive impairment, anorexia, fatigue, decreased social behavior) commonly co-occur with documented immune activation in multiple disease conditions.
Behavioral responses to infection follow a stereotyped pattern similar across different etiologies, suggesting common biological mechanisms.
Cytokine production is associated with immune responses to infection and inflammation across acute, recurrent, and chronic viral illnesses and autoimmune conditions.
Cytokine exposure occurs both during active infection and during immunotherapy for malignancies and chronic infections.
Inferred Conclusions
Cytokine-dependent mechanisms within the central nervous system likely mediate the behavioral and neuropsychiatric responses observed during infection and systemic inflammation.
Corticotropin-releasing factor (CRF) and prostaglandins of the E series represent plausible pathways by which peripheral cytokines influence brain function and behavior.
Systematic prospective studies correlating immune markers, neuroendocrine responses, and behavioral changes are needed to establish the cytokine-behavior relationship.
Remaining Questions
What are the specific dose-response relationships between circulating cytokine levels and severity of neuropsychiatric symptoms?
How do temporal patterns of cytokine production correlate with the onset and resolution of behavioral and cognitive changes?
What This Study Does Not Prove
This review does not establish causation between cytokines and psychiatric symptoms; it proposes mechanisms without presenting original data. It does not prove that cytokines are the sole or primary cause of neuropsychiatric syndromes in ME/CFS or other conditions, nor does it demonstrate that treating cytokine abnormalities would resolve these symptoms.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.